Background. We developed and evaluated a comprehensive, ongoing intervention for families of schizophrenic patientsappropriate for China'scomplexfamilyrelationships anduniquesocial environment.
Over 90% of the estimated 4.5 million schizophrenic individuals in China live with their families (Phillips, 1993) , and virtually all out-patient visits for schizo phrenic patients include patients' family members. It would, therefore, seem highly appropriate to use family-based interventions, but no indigenous Chinese family therapy techniques have evolved, largely because Chinese mental health clinicians have no training in the evaluation and management of family problems. Theusefulness offamily interventions for schizophrenia in the West (Lam, 1991; Kavanagh, 1992) may not be suitable for China, due to the complex family relationships in Chinese culture, the characteristics of the Chinese mental health system, and the unique social environment of the People's Republic of China.
Developing a family intervention appropriate for China
We worked intensively with 30 families of schizo phrenic patients for over two years, testing and adapting a variety of approaches that have been used in the West. These included educational approaches (Abramowitz & Coursey, 1989) , relatives' groups (Vaughan et al, 1992) , family therapy (Leff et al, 1990) , behavioural treatments (Falloon et a!, 1985;  Tarrier et a!, 1989), and multi-component psycho social treatment (Leff et a!, 1985) . It soon became evident that these approaches make assumptions that do not hold true in China: they assume patients and family members realise that counselling or â€˜¿ talking therapy' is a legitimate method of treating mental disorders; that the primary social goal of the family is to change the dependent individual into an independently functioning member of society (Grinspoon, 1989) ;and that there is an overall mental health care system that will provide ongoing services to patients and families during and after the intervention. The circumstances are very different in China, so our intervention had to be modified accordingly.
Families' expectation of the clinical encounter
Most Chinese are unfamiliar with the concept of counseffing or psychotherapy. Chinese families fmd it strange to talk with clinicians at length about the problems of having the patient in the home, as this contravenes the strongly held belief that family matters should not be discussed with outsiders, and it is not consonant with their expectations of the clinical encounter â€"¿ a brief exchange with an authoritative physician who provides a prescription. Compared with Western interventions, in the early stages of family intervention in China much more effort needs to be placed on transforming family members' perception of the role of the physician 240
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from that of a pill-provider to that of an informed family advisor.
Goals of families of schizophrenic patients
The ultimate social goal of family members of mentally ill individuals in China is to develop a sustainable family-based support system for the 
Minimal services for the mentally ill
In most of mainland China there is no community based mental health care system to which the family can be referred at the end of a time limited family intervention (Phillips & Pearson, in press). Some of the major cities (Shanghai, Beijing, and a few others) have sheltered workshops for psychiatric patients, and a few have community based mental health clinics and experimental pro grammes of supervision of patients by non professionals (Zhang et a!, in press). In the vast majority of urban areas the psychiatric hospital's out-patient department is the only form of professional support available. In most of these there is no system of regular appointments, so families of schizophrenic patients see different clinicians at each visit and are given a prescription for a neuroleptic after a cursory evaluation by someone who knows little of the patient's history. There are no voluntary organisations that provide services to the mentally ill, no halfway houses or alternative living facilities, no recreational centres for the mentally ill, no family support organisations, and -most importantly â€"¿ no social workers (Pearson & Phillips, in press) or community psychiatric nurses (Bueber, 1993) who could provide home-based care.
The characteristics of the available mental health services dictated several of the parameters of our intervention.
(a) Intervention is provided by hospital-based physicians and nurses since these are the only mental health professionals available in China.
(b) The treating clinicians needed special training because psychiatrists and psychiatric nurses in China have no experience in the evaluation and manage ment of the family and social problems faced by mentally ill patients. (f) The intervention includes, to the extent possible, support services that are typically provided by community social workers and community psychiatric nurses in the West.
Method
After more than two years of trial and error, the family-based intervention was sufficienfly developed to merit formal evaluation. Starting in January 1990, patients and families were enrolled in the evaluation trial. As soon after admission to the Shashi Psychiatric Hospital as possible, an unselected sample of patients from Shashi or Jingzhou (adjacent â€˜¿ medium-sized' Chinese cities with a total population of 450 000) who lived with at least one adult family member were assessed to determine if they met DSM-III-R criteria for schizophrenia (American Psychiatric Association, 1987) . If so, a detailed history was obtained from the patient and family members; if they gave written consent to participate, they were randomly assigned to the family inter vention (experimental) or the standard care (control) group. FAMILY-BASEDINTERVENTIONIN CHINA
Family intervention
The intervention has three phases: a 2-3 month introduction, 1â€"2 years of treatment, and ongoing maintenance. At enrolment, families are provided with information booklets about schizophrenia.
Family members are seen two or three times during the patient's hospitalisation (which usually lasts 2 to 3 months); ifthe patient's clinical condition is stable he or she also attends these 45-minute sessions. For the first few months after discharge the family (including the patient) are seen every two to three weeks. The main objectives during this intro ductory phase are to establisha trusting, empathic relationship with the family, to educate them about the illness, to develop an effective method of medication management, and to introduce this unusual talking therapy.
Once the family has adapted to interacting with clinicians, the treatment phase begins. Monthly, 45-minute counselling sessions in the out-patient clinic with the patient and co-resident family members are combined with a monthly 90-minute family group. These are supplemented by individual sessions with patients and family members, home visits, interviews with leaders of the patient's work unit, and with potential spouses and important members of the extended family. Frequency of contact with the family often increases at times of crisis. The issues addressed in the sessions, the people participating, and the primary therapy (education, behavioural training, problem-solving, counselling, etc.) will change over time in parallel with changes in the patient's clinical and social status and in the family's attitudes. During the familygroup sessions the therapists lead discussions on common problems such as medication usage, detecting relapse, con trolling violence, marriage, dealing with stigma, and mental health laws. Records of these group discussions are typed and sent to each family every month along with information about forthcoming topics.
Once the patient's social functioning has improved and the family has developed an effective coping strategy, the maintenance phase can begin. Families are seen every two to three months for drug super vision and ongoing monitoring of symptoms, and are also expected to attend the monthly group meetings. The goal is to reduce the medication to the lowest effective dose and to have an ongoing relation ship with the family, to ensure they will contact the therapist in the event of a crisis or exacerbation of the patient's symptoms.
Smooth progress is not always made. Some patients adamantly refuse to take medication or participate in any form of treatment; some have mild symptoms or have no serious effect on the family members, who refuse to participate in post hospitalisation follow-up; not all families can adapt to this styleof treatment; somerefuse to acceptthat their family member has a mental illness; some drop out during treatment when they realise that the â€˜¿ fmal cure' they are desperate for will not be provided; and some are so apathetic or over-involved that any form of outside intervention is impossible. As far as possible we try to accommodate varying needs by applying different methods such as making regular home visits, seeing the patient without family members (quite uncommon in China), individually counselling disturbed family members, and assisting in the rehospitalisationof relapsedpatients.The aim is to maintain contact, so that families are willing to ask for assistancein a crisis and, at some later point, re-engage in treatment.
Standard care
Standard post-hospitalisation care for schizophrenic patients in our hospital is similar to that provided in most other urban centres in China. At discharge the family is given a prescription for two to three months of medication and told to have the patient take a specifieddoseto completion. Some in-patient clinicians advise the family to go to the psychiatric hospital's out-patient department for follow-up, but those who do seek follow-up care prefer to get prescriptions from the patient's in-patient clinician (if willing to see them). No appointments are made in the out-patient department, so very few patients make regular visits; in many cases family members make sporadic visits for prescription renewal and only bring the patient to the clinic when an exacerbationof symptomsrequiresrehospitalisation.
Evaluation of outcome
The clinical statusof enrolled patients at admission and discharge was evaluated using Chinese versions of the Scale for Assessment of Positive Symptoms (SAPS), the Scale for Assessment of Negative Symptoms(SANS), and the Brief PsychiatricRating Scale (BPRS), all of which have excellent reliability and validity in China (Phiffips et a!, 1990 (Phiffips et a!, , 1991 Zhang, 1983) .At six-month intervals after discharge two experienced clinical researchers who were blind to patients'treatmentstatusconductedhomeinterviews with patients and family members to assess patients' clinical and social functioning over the previous six months. SAPS, SANS, and BPRS were used to assess the severity of clinical symptoms; the overall level of functioning was assessed using the Global Assessment of Functioning scale (GAF) (American Psychiatric Association, 1987) shown that this simple measure of family burden can discriminate between different types of families. The number and duration of hospitalisations after the index discharge was determined with information from the family and hospital charts. Outcome variables include the level of clinical and social functioning, the number and duration of rehospitalisations, relapse, duration of employ ment, duration of drug compliance (i.e. time for which the patient took over 50% of the dosage recommended at the time of last contact with a psychiatrist), and the effect of the illness on the family. (e) there was a severe degree of psychosocial dysfunction as assessed by SDSS (greater than 80% disability).
Resufts

Characteristics of the sample
Of the 77 families who met the enrolment criteria, 14 (18%) refused to participate. The remaining 63
were randomly assignedto the experimental group (n = 34) or the control group (n = 29). The characteristics of the 63 patients and their households were as follows: 43 (68%) were male; mean (s.d.) age at index admission was 31 (10) years (range 17 to 54); mean years of schooling was 9(2); 24(38%) had nevermarried, 35(56%) werecurrently married, and 5 (6%) were separated, divorced, or 
Compliance with treatment
At the time of this interim analysis,the families had been followed for a mean of 25 (5) months after the indexdischarge(range10to 34).The 34experimental group families had made a mean of 14 (10) visits to the clinic (range 0 to 35) and received a mean of 2.7
(2.5) home visits (range 0 to 10). This represents an
average of 8.1 contacts with each family for each year of follow-up (not including attendance at the monthly family group meetings).
Despite agreeing to participate in the study and to have visits by an independent evaluator every six months, compliance with the family-based inter vention varied considerably. Families and patients were separately classified as â€˜¿ actively compliant' (the patient or family members regularly attended appointments in the out-patient clinic), â€˜¿ passively compliant' (the patient or family members would come to the clinic only if reminded by a letter or readily accepted home visits), and â€˜¿ non-compliant' (the patient or family members never came to the clinic and resisted or completely refused home visits).
According to these criteria 56% (19/34) of the experimental group patients were actively compliant, 21% (7/34) were passively compliant, and 23% (8/34) were non-compliant. Among family members, 41 Â°lo (14/34) were actively compliant, 32Â°lo (11/34) were passively compliant, and 27Â°lo (9/34) were non compliant. There were three families in which family members participated but the patient was non compliant, four families in which the patient participated but the family members were non compliant, and five families in which both the patient and family were non-compliant. Despite regular letters and encouragement from the treating clinicians, 32% (11/34) of the families never attended the monthly family group meetings, mainly because of fear of exposure of the â€˜¿ family secret'. Members of about half of the 23 families that participated in the group meetings attended in any one month. All of these families -compliant and non-compliant -are included in the subsequent analysis. The primary focus of standard treatment is to maintain patients on medication, so control group Table 1 Proportions of schizophrenic patients who experienced rehospitalisation and relapse patients were classified as compliant if they were compliant with medication (see definition above) for at least 75% of the non-hospitalised follow-up period. According to this standard, 59% (17/29) of the control group patients were compliant and 41Â°lo
(12/29) were non-compliant.
Outcome
One patient in the experimental group committed suicide 10 months after the index discharge (he hanged himself during an acute anxiety episode that occurred four days after a first dose of long-acting haloperidol), and one patient in the control group committed suicide by poisoning 10 months after the index discharge. Another experimental group patient died from the complications of inadequately treated diabetes 20 months after the index discharge. These deaths were treated as relapses in the analysis. Suicide and premature death from inadequately treated medical conditions is fairly common among schizo phrenic patients in China; there was also one suicide by poisoning among the 14 patients who refused to participate in the study.
The main results for the study are shown in Tables   1, 2 , and 3. The numbers of patients in the groups at different time periods varies because the length of follow-up after hospitalisation differed. More of the control group patients than experimental group patients had experienced a rehospitalisation at the end of each of the time periods, and the mean duration of rehospitalisationwas much longer in the control group; these differences were statistically significant at the 12-month and 18-month follow ups. Overall, the experimental group subjects were hospitalised for 6.8 days per follow-up year compared to 31.6 days in the control group, a 4.5-fold difference.
At eachstageof the follow-up more control group subjects experienced a relapse than experimental group subjects,but the differenceis only statistically significant at the 12-month follow-up. At the 6, 12, and 18-month post-hospitalisation evaluations the meanscoresfor the five clinicaland socialfunctioning scales (i.e. SAPS, SANS, BPRS, OAF, and SDSS) all indicated less severe pathology in the experimental group than in the control group; but thesedifferences only reachedstatistical significance for the BPRS, OAF, and SDSS scores at 12 months and the SAPS, BPRS, OAF, and SDSSscoresat 18 months. The mean level of social dysfunction over the entire follow-up period (i.e. the group mean of each subject's average six-monthly SDSS scores) was 39% in the experimental group and 49% in the control group (Mann-Whitney Z= 2.64, P= 0.0068).
The other goalsof the intervention wereto increase the occupational functioning and medication com plianceof patientsand to decrease the family burden. Table 2 shows that experimental group patients worked for a greater proportion of the follow-up period than control group patients; this difference was statistically significant at the 18-month follow up. Overall, experimental group subjects worked for 46.2% of the follow-up period while control group subjects only worked for 24.4% of the follow-up period.
Table 2 also shows that experimental group patients complied with psychiatrists' recommendations re garding medication for a greater proportion of the Table 3 Family members' subjective assessmentof the effect of the patient's illness on various aspects of family functioning overthe follow-upperiod' â€˜¿ Assessed on a four-point scale(0 = none, 1= mild, 2 = moderate,3 = severe)at six-monthly intervals;valuesareaveragedover the entire follow-upperiod.
Family intervention groupControI groupx2d.f.PActivelyPassivelyCompliantNon compliantcompliant(n = 1 7)compliant(n=19)ornon (n=12)compliantIn = 15) Rehospitalisationn26655.1330 follow-up period than control group patients, but these differences were not statistically significant.
Overall, experimental group patients used over 50%
of the recommended antipsychotic dosage for 86.3% of the follow-up period compared with 73.8% for control group patients.
Table 3 indicates significant differences in the level of burden experienced by the experimental and control families. The lower rate and shorter duration of hospitalisations and the longer time in gainful employment of the experimental group patients probably reduces the economic burden experienced by their families. The effect of the patient on non ill family members' interpersonal relationships and emotional well-being in experimental group families was significantly less severe compared with control group families. Table 4 compares the results for compliant and non-compliantpatientsin theexperimental andcontrol groups. In all cases the outcomes arebest for compliant experimental group patients and worst for non compliant control group patients, but several of the results werenot statisticallysignificant. Despite having almost identical levels of drug utilisation, the actively compliant experimental group patients had much better outcomes than the compliant control group patients. Experimental group patients from families with passively compliant or non-compliant family members or with family members who did not attend the monthly family group meetings have poorer outcomes than patients with actively compliant family members and family members who attended the family group, but in most casesthese differences were not statistically significant.
Economic assessment
Discussion
Comparedwith control group patients, eachpatient in the family intervention group was hospitalised 24.8 days less per year and worked for 2.6 months more per year. Oiven the mean cost of psychiatric (b) The treatment method we developed is an ongoing treatment, but we have only presented the results for the first 18 months after discharge because the number of subjectsfollowed for longer periods is not yet sufficient to make meaningful inferences. The long-term efficacy of this approach will be reported in subsequent papers.
(c) As in all family intervention studies, there was some difficulty in maintaining blinding since some families spontaneously state that they received treat ment during the follow-up evaluations. This problem wasminimised by instructing the families not to state who had provided treatment and by ensuring that the evaluators were unaware of the purpose of the study.
(d) The reliability of the rehospitalisationdata was excellent because (accordingto the family respondents) none of the patients was hospitalised in out-of-area hospitals.Therewas,however,someproblemin deter mining a clinical relapsewithout rehospitalisation if the patientrefuseda follow-up evaluationor wassoill that it was impossibleto completeSAPS, SANS, and BPRS. This problemwasminimisedby includingscales that rely on evaluators' and family members'assess meats (OAF and SDSS) to determine relapse. Very brief relapses that occurred in the intervals between the six-monthly evaluations were not captured unless the patient required rehospitalisation; it is
likely that the few casesfor whom this occurred were evenly distributed between the two groups.
(e)Virtually all Chinesepatientstakelessmedication than prescribed and so we felt that defining â€˜¿ drug compliance' as full compliance with the last prescribed dosage would not reveal any differences between the groups. But our definition of the duration of drug complianceasthetime thepatienttook morethan 50% of the last prescribed dosage proved too lax, as it resulted in unrealistically high levels of compliance. Moreover, the determination of drug usage was based on family members' reports; pill counts would have provided more accurate information, but as many patients receivedmultiple prescriptions over the six month follow-up periods this was not practical.
(1)Themeasure ofwork functionemployed-thetime on thejob -was fairlyeasy to determine accurately from family members, but it does not reveal the quality of theworkperformed. To make qualitative assessments, however, wouldrequiremuchmoredetailedinformation.
(g)The 18% refusal rate is only slightly higher than the 13% median refusal rate in Western studies (Kavanagh, 1992) and the non-attendancerate in the family support group of 32% is similar to the 45% rate reported by Leff et a! (1990) , but the rates of non compliance with the individual family sessionsin patients and family members of23% and 27%, respec tively, are much higher than the reported 7% median dropout rate in Western studies (Kavanagh, 1992) . Non-compliance does not, however, confound the re sultsbecauseall subjectsare included in the analysis.
The intervention will, nonetheless, need to be modified to make this â€˜¿ talking therapy' more acceptable to Chinese patients and their family members.
Generalisabllity of the results
We believethat the abovelimitations do not seriously bias the results. Oiven the randomised design we are confident in the validity of the overall findings of the study-that this family-based intervention results in lessrehospitalisationand better social functioning of Chinese schizophrenic patients and a decreased burden for their families. Our sample was an unselected group of urban schizophrenic patients living with family memberswho werewiffing to participatein the study. Since over 90% of Chinese schizophrenic patientslive with family members,since82% (63/77) of eligible families agreed to participate, and since the urban schizophrenicpatientsadmitted to our hospital
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are similar to those elsewherein China (Phillips, 1993) , these results can be generalised to at least three quartersof urban schizophrenicpatients.The preva lence of schizophrenia in China's 238 million urban residents 15 years of age or older is 6.07 per 1000 (Coordinating Epidemiological Group for Twelve Regions, 1986) ; thus these results apply to at least 1.06million of the 1.44million urban schizophrenic patients in China.
This treatment method is suitable for China and for other countries with limited mental health resources because there are minimal staff requirements, it can be provided in existing institutions (i.e. out-patient departments of psychiatric hospitals), and it is signifi cantly lessexpensivethan standard care. Given the estimated US $149 saving per treated family, the wide spread use of this intervention could result in savings of US $158 million per year -equivalentto l.44Â°lo of China's estimatedtotal healthsectorexpendituresfor 1991 (Anonymous, 1992 . Moreover, the rapidly in creasingcostof hospitalisation(from 1984to 1992the mean per day cost in our hospital rose more than fivefold) will increasethe economicsuperiorityof the family intervention.
